Medication management Archive

Articles

FDA approves nasal spray to treat rapid heart rhythm

In late 2025, the FDA approved a nasal spray to treat a sporadic, rapid heart rhythm called paroxysmal supraventricular tachycardia (PSVT). The self-administered spray, called etripamil (Cardamyst), may help people avoid emergency room treatment for PSVT.

Result 1 - 1 of 1

Free Healthbeat Signup

Get the latest in health news delivered to your inbox!

Sign Up
Harvard Health Publishing Logo

Thanks for visiting. Don't miss your FREE gift.

25 Gut Health Hacks is yours absolutely FREE when you sign up to receive health information from Harvard Medical School.

Sign up to get tips for living a healthy lifestyle, with ways to lessen digestion problems…keep inflammation under control…learn simple exercises to improve your balance…understand your options for cataract treatment…all delivered to your email box FREE.

Harvard Health Publishing Logo

Stay on top of latest health news from Harvard Medical School.

Plus, get a FREE copy of 25 Gut Health Hacks.

Harvard Health Publishing Logo

Stay on top of latest health news from Harvard Medical School.

Plus, get a FREE copy of 25 Gut Health Hacks.